Hasil Pencarian - Bryan Oronsky

Perbaiki Hasil
  1. 1
    Profile EpicentRx, Inc

    Profile EpicentRx, Inc oleh Bryan Oronsky

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    What Exactly Is Inflammation (and What Is It Not?)

    What Exactly Is Inflammation (and What Is It Not?) oleh Bryan Oronsky, Scott Caroen, Tony Reid

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Commentary on oncolytic viruses: past, present, and future

    Commentary on oncolytic viruses: past, present, and future oleh Christopher Larson, Bryan Oronsky, Tony R Reid

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    RRx-001 Increases Erythrocyte Preferential Adhesion to the Tumor Vasculature

    RRx-001 Increases Erythrocyte Preferential Adhesion to the Tumor Vasculature oleh Vinay P. Jani, Robert Asaro, Bryan Oronsky, Pedro Cabrales

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply

    Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply oleh Bryan Oronsky, Christopher Larson, Scott Caroen, Tony R. Reid

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas

    Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas oleh Bryan Oronsky, Patrick C. Ma, Daniel Morgensztern, Corey A. Carter

    Diterbitkan 2017-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    A short discussion about the SARS-CoV-2 mRNA-1273 vaccine

    A short discussion about the SARS-CoV-2 mRNA-1273 vaccine oleh Bryan Oronsky, Harry E. Gruber, Wendy Reiners, Tony R. Reid

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    What's New in SCLC? A Review

    What's New in SCLC? A Review oleh Bryan Oronsky, Tony R. Reid, Arnold Oronsky, Corey A. Carter

    Diterbitkan 2017-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Impact of hemoglobin nitrite to nitric oxide reductase on blood transfusion for resuscitation from hemorrhagic shock

    Impact of hemoglobin nitrite to nitric oxide reductase on blood transfusion for resuscitation from hemorrhagic shock oleh Chad Brouse, Daniel Ortiz, Yan Su, Bryan Oronsky, Jan Scicinski, Pedro Cabrales

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    A Review of Newly Diagnosed Glioblastoma

    A Review of Newly Diagnosed Glioblastoma oleh Bryan Oronsky, Tony R. Reid, Arnold Oronsky, Navjot Sandhu, Susan J. Knox

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma

    A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma oleh Howard Fine, Tony Reid, Scott Caroen, Bryan Oronsky, Nacer Abrouk, Nicholas Butowski

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist

    RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist oleh Bryan Oronsky, Lori Takahashi, Richard Gordon, Pedro Cabrales, Scott Caroen, Tony Reid

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Rewriting the Epigenetic Code for Tumor Resensitization: A Review

    Rewriting the Epigenetic Code for Tumor Resensitization: A Review oleh Bryan Oronsky, Neil Oronsky, Jan Scicinski, Gary Fanger, Michelle Lybeck, Tony Reid

    Diterbitkan 2014-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Hypothesis: AdAPT-001 and pseudoprogression – when seeing is not necessarily believing

    Hypothesis: AdAPT-001 and pseudoprogression – when seeing is not necessarily believing oleh Anthony Conley, Christopher Larson, Bryan Oronsky, Meaghan Stirn, Tony R Reid, Scott Caroen

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet

    A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet oleh Hope Cottrill MD, Stephanie Cason, Scott Caroen, Bryan Oronsky MD, Elvis Donaldson MD

    Diterbitkan 2018-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Superior Vena Cava Syndrome in a Patient with Small-Cell Lung Cancer: A Case Report

    Superior Vena Cava Syndrome in a Patient with Small-Cell Lung Cancer: A Case Report oleh Christina Brzezniak, Bryan Oronsky, Corey A. Carter, Bennett Thilagar, Scott Caroen, Karen Zeman

    Diterbitkan 2017-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Nucleocapsid as a next-generation COVID-19 vaccine candidate

    Nucleocapsid as a next-generation COVID-19 vaccine candidate oleh Bryan Oronsky, Christopher Larson, Scott Caroen, Farah Hedjran, Ana Sanchez, Elena Prokopenko, Tony Reid

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Phase 1 pilot study of RRx-001 + nivolumab in patients with advanced metastatic cancer (PRIMETIME)

    Phase 1 pilot study of RRx-001 + nivolumab in patients with advanced metastatic cancer (PRIMETIME) oleh Tony Reid, Bryan Oronsky, Scott Caroen, Mary Quinn, Jeannie Williams, Pedro Cabrales, Nacer Abrouk

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic"

    RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic" oleh Bryan Oronsky, Corey A. Carter, Scott Caroen, Curtis Scribner, Arnold Oronsky, Tony R. Reid

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma Patient

    Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma Patient oleh Santosh Kesari, Jeannie Williams, Erica Burbano, Meaghan Stirn, Scott Caroen, Bryan Oronsky, Tony Reid, Chris Larson

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: